IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary.
Mr. Kenny has been with IntelGenx since 2016. He is an attorney specializing in intellectual property and commercial pharmaceutical law, who has developed strong technical expertise across a range of legal functions, managing litigation and advising on commercial partnerships, while also building a strong intellectual property portfolio for the company’s oral film technologies.
Most recently, Mr. Kenny was director of intellectual property and legal affairs with IntelGenx. In his new role, he will continue to oversee IntelGenx’s legal activities, including intellectual property management and cannabis-related matters.
Prior to joining IntelGenx, Mr. Kenny was an attorney in a Montreal intellectual property boutique law firm, advising clients on various intellectual property and commercial matters.
“I believe Tommy is exceptionally well qualified with his strong leadership skills, expertise in both law and science, and strategic intellectual property portfolio planning insights to manage IntelGenx’s legal affairs,” Dr. Horst Zerbe, CEO of IntelGenx, said in a statement.
“His promotion comes at a pivotal time for IntelGenx as we continue to make progress on our key programs, while taking strategic steps toward the future with our recent partnering in the cannabis and psychedelic fields.”
